.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer in 2015 for an immense $43 ...
.On the heels of a phase 3 win that neglected to impress investors, Ironwood Pharmaceuticals is actu...
.Don't quit Monte Rosa Therapeutics currently. The Boston-based biotech is actually having a ball af...
.Accept to recently's Chutes & Ladders, our summary of considerable leadership hirings, firings a...
.Commemorating his company's upsized initial public offering (IPO), Septerna chief executive officer...
.AbbVie has returned to the resource of its antipsychotic giant Vraylar seeking yet another runaway ...
.GenSight Biologics is actually full weeks off of lacking funds. Once more. The biotech only possess...
.Monopar Therapeutics is recouping a medication coming from the dump of AstraZeneca's rare illness p...
.With brand new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of experts ...
.After developing a genetics therapy partnership with Dyno Therapeutics in 2020, Roche is back for a...